bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells - PubMed (original) (raw)
. 1992 Mar 1;79(5):1291-8.
Affiliations
- PMID: 1536952
Free article
bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells
D Delia et al. Blood. 1992.
Free article
Abstract
The present study provides immunobiochemical and molecular data on the differentiation-linked expression of the bcl-2 proto-oncogene in normal and neoplastic myeloid cells. Using a recently developed monoclonal antibody (MoAb) to the bcl-2 molecule, staining of normal bone marrow myeloblasts, promyelocytes, and myelocytes, but neither monocytes nor most polymorphonuclear cells, was demonstrated. By two-color flow cytometric analysis, bcl-2 was evidenced in CD33+ and CD33+/CD34+ myeloid cells as well as in the more primitive CD33-/CD34+ population. The leukemic cell lines HL-60, KG1, GM-1, and K562 were bcl-2 positive together with 11 of 14 acute myeloid leukemias (AML) and three of three chronic myeloid leukemias (CML) in blast crises; six of seven CML were negative. Among myelodysplastic cases, augmentation of the bcl-2 positive myeloblastic compartment was found in refractory anemia with excess of blasts (RAEB) and in transformation (RAEB-t). Western blots of myeloid leukemias and control lymphocytes extracts evidenced an anti-bcl-2 immunoreactive band of the expected size (26 Kd). Moreover, the HL-60 and KG1 cell lines, both positive for the bcl-2 protein, exhibited the appropriate size bcl-2 mRNA (7.5 Kb). These findings clearly indicate that the bcl-2 gene is operative in myeloid cells and that the anti-bcl-2 MoAb identifies its product and not a cross-reactive epitope. Induction of HL-60 differentiation toward the monocytic and granulocytic pathways was accompanied by a marked decrease in bcl-2 mRNA and protein levels; bivariate flow cytometric analysis showed that the fraction becoming bcl-2 negative was in the G1 phase of the cell cycle. These data establish that the bcl-2 proto-oncogene is expressed on myeloid cells and their progenitors and is regulated in a differentiation-linked manner.
Similar articles
- Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
Wetzler M, Talpaz M, Van Etten RA, Hirsh-Ginsberg C, Beran M, Kurzrock R. Wetzler M, et al. J Clin Invest. 1993 Oct;92(4):1925-39. doi: 10.1172/JCI116786. J Clin Invest. 1993. PMID: 8408645 Free PMC article. - T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K, Mizuno S, Harada M, Kimura N, Kinjyo M, Shibuya T, Shimoda K, Takeshita M, Okamura S, Matsumoto I, et al. Akashi K, et al. Exp Hematol. 1993 Jun;21(6):743-8. Exp Hematol. 1993. PMID: 7684698 - c-Cbl tyrosine phosphorylation and subcellular localization in human primary leukemic cells.
Brizzi MF, Rosso A, Dentelli P, Ferrero D, Lanfrancone L, Pegoraro L. Brizzi MF, et al. Exp Hematol. 1998 Dec;26(13):1229-39. Exp Hematol. 1998. PMID: 9845379 - Human myeloid leukemia cell lines: a review.
Koeffler HP, Golde DW. Koeffler HP, et al. Blood. 1980 Sep;56(3):344-50. Blood. 1980. PMID: 6996765 Review.
Cited by
- All-trans-retinoic acid induces apoptosis in Leydig cells via activation of the mitochondrial death pathway and antioxidant enzyme regulation.
Tucci P, Cione E, Perri M, Genchi G. Tucci P, et al. J Bioenerg Biomembr. 2008 Aug;40(4):315-23. doi: 10.1007/s10863-008-9156-8. Epub 2008 Jul 31. J Bioenerg Biomembr. 2008. PMID: 18668354 - Immunohistochemical localization of mdm-2, p27Kip1 and bcl-2 in Warthin's tumor of the parotid gland.
Abd-Elhamid ES, Elshafei MM. Abd-Elhamid ES, et al. Diagn Pathol. 2009 May 16;4:14. doi: 10.1186/1746-1596-4-14. Diagn Pathol. 2009. PMID: 19445705 Free PMC article. - A novel method for long term bone marrow culture and genetic modification of murine neutrophils via retroviral transduction.
Zemans RL, Briones N, Young SK, Malcolm KC, Refaeli Y, Downey GP, Worthen GS. Zemans RL, et al. J Immunol Methods. 2009 Jan 30;340(2):102-15. doi: 10.1016/j.jim.2008.10.004. Epub 2008 Nov 14. J Immunol Methods. 2009. PMID: 19010330 Free PMC article. - Bcl-2 gene family and related proteins in mammary gland involution and breast cancer.
Schorr K, Li M, Krajewski S, Reed JC, Furth PA. Schorr K, et al. J Mammary Gland Biol Neoplasia. 1999 Apr;4(2):153-64. doi: 10.1023/a:1018773123899. J Mammary Gland Biol Neoplasia. 1999. PMID: 10426394 Review. - FAS promoter polymorphism: outcome of childhood acute myeloid leukemia. A children's oncology group report.
Mehta PA, Gerbing RB, Alonzo TA, Elliott JS, Zamzow TA, Combs M, Stover E, Ross JA, Perentesis JP, Meschinchi S, Lange BJ, Davies SM. Mehta PA, et al. Clin Cancer Res. 2008 Dec 1;14(23):7896-9. doi: 10.1158/1078-0432.CCR-08-0418. Clin Cancer Res. 2008. PMID: 19047119 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials